Skip to content
Licensed Unlicensed Requires Authentication Published online by De Gruyter March 19, 2024

Improving HCV diagnosis following a false-negative anti-HCV result

  • Xia Long ORCID logo , Yu Chen , Minggang Yin and Weiping Liu EMAIL logo

Corresponding author: Weiping Liu, Department of Clinical Laboratory, Zigong First People’s Hospital, No. 42, Shangyihao Road, Zigong 643000, Sichuan, P.R. China, E-mail:

Funding source: the Foundation of Key Science and Technology Project of Zigong of China

Award Identifier / Grant number: 2019YLSF04

  1. Research ethics: The local Institutional Review Board deemed the study exempt from review.

  2. Informed consent: Not applicable.

  3. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Competing interests: The authors state no conflict of interest.

  5. Research funding: This work was supported by the Foundation of Key Science and Technology Project of Zigong of China (2019YLSF04).

  6. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Liu, CH, Kao, JH. Acute hepatitis C virus infection: clinical update and remaining challenges. Clin Mol Hepatol 2023;29:623–42. https://doi.org/10.3350/cmh.2022.0349.Search in Google Scholar PubMed PubMed Central

2. Li, T, Zhang, H, Fang, Z, Yin, J, Rao, W. Clinical performance of the MAGLUMI Anti-HCV (CLIA) Test for detection of hepatitis C virus antibodies. J Virol Methods 2023;319:114770. https://doi.org/10.1016/j.jviromet.2023.114770.Search in Google Scholar PubMed

3. Moorman, AC, Drobenuic, J, Kamili, S. Prevalence of false-positive hepatitis C antibody results, National Health and Nutrition Examination Study (NHANES) 2007-2012. J Clin Virol 2017;89:1–4. https://doi.org/10.1016/j.jcv.2017.01.007.Search in Google Scholar PubMed PubMed Central

4. Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2:161–76. https://doi.org/10.1016/s2468-1253(16)30181-9.Search in Google Scholar PubMed

5. Patel, K, Muir, AJ, McHutchison, JG. Diagnosis and treatment of chronic hepatitis C infection. BMJ 2006;332:1013–17. https://doi.org/10.1136/bmj.332.7548.1013.Search in Google Scholar PubMed PubMed Central

6. WHO. Guildlines on hepatitis B and C testing. Geneva: World Health Organization; 2017.Search in Google Scholar

7. CDC. Testing for HCV infection: an update of guidance for clinicians and laboratorians. MMWR Morb Mortal Wkly Rep 2013;62:362–5.Search in Google Scholar

8. Deepjyoti, K, Sangeeta, D, Kailash, C, Giasuddin, A. Laboratory evaluation of hepatitis C virus infection in patients undergoing hemodialysis from North East India. J Clin Exp Hepatol 2022;12:475–82. https://doi.org/10.1016/j.jceh.2021.05.011.Search in Google Scholar PubMed PubMed Central

Received: 2024-02-01
Accepted: 2024-03-05
Published Online: 2024-03-19

© 2024 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 27.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2024-0161/html
Scroll to top button